Jupiter Neurosciences (JUNS) Interest & Investment Income (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Interest & Investment Income of $10212.0 for Q3 2025, up 44300.0% year-over-year from N/an in Q3 2024, and down 21.75% quarter-over-quarter from $13050.0 in Q2 2025.
Jupiter Neurosciences (JUNS) Interest & Investment Income (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Interest & Investment Income for 3 consecutive years, with $10212.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Interest & Investment Income rose 44300.0% year-over-year to $10212.0; the TTM figure through Sep 2025 stood at $39046.0 (up 188.36% YoY), while the FY2024 annual figure was $5557.0, up 1052.9% from the prior year.
- Interest & Investment Income declined to $10212.0 in Q3 2025 per JUNS's latest filing, from $13050.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $13050.0 in Q2 2025 and bottomed at -$44329.0 in Q4 2023.
- Historically, Interest & Investment Income has averaged -$553.78 across 3 years, with a median of $161.0 in 2023.
- Annual changes were most pronounced in 2024 — Interest & Investment Income plunged 85.71% — and 2025, when it soared 44300.0%.
- Jupiter Neurosciences' Interest & Investment Income stood at -$44329.0 in 2023, then surged by 112.22% to $5419.0 in 2024, then surged by 88.45% to $10212.0 in 2025.
- Business Quant data shows JUNS's Interest & Investment Income at $10212.0 in Q3 2025, $13050.0 in Q2 2025, and $10365.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 10,068.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10,212.00 |
| Jun 30, 2025 | 13,050.00 |
| Mar 31, 2025 | 10,365.00 |
| Dec 31, 2024 | 5,419.00 |
| Sep 30, 2024 | 23.00 |
| Jun 30, 2024 | 53.00 |
| Mar 31, 2024 | 62.00 |
| Dec 31, 2023 | -44,329.00 |
| Sep 30, 2023 | 161.00 |